Discover 262 paid clinical trials in Delaware. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Delaware offers numerous clinical research opportunities, including paid studies for healthy volunteers and those with specific medical conditions. Major centers in Wilmington, Dover, and Newark are actively recruiting participants, offering access to emerging treatments and innovative medical care.
Filter
1
Filter results
Results: 262
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Sherbrooke, North Massapequa NY, Saint-Charles-Borromee,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06959095
Phase 3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Halifax, South Portland ME, Boston MA, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase 3, Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
for
Gastroesophageal Adenocarcinoma
Location: Montreal, Newark DE, Washington D.C. DC, Pittsburgh PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07069712
Phase 2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase 2, Recruiting
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
for
Cytomegalovirus (CMV)
Location: Wilmington DE, St. Petersburg FL, Cincinnati OH,
Sponsor: Takeda
Sex: All
Age: 0 - 17
Code: NCT05319353
Phase 3, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans
for
Hypertension
Location: Newark DE
Sponsor: University of Delaware
Sex: All
Age: 18+
Code: NCT07071077
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Worcester MA, Quebec, White Plains NY, The Bronx NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: New Haven CT, The Bronx NY, Brooklyn NY, Hackensack NJ,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase 2, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: South Weymouth MA, Foxborough MA, Methuen MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase 2, Recruiting
Stress Hydrocortisone In Pediatric Septic Shock
for
Septic Shock
Location: Halifax, Boston MA, Quebec, Livingston NJ, Montreal,
Sponsor: Jerry Zimmerman
Sex: All
Age: 0 - 17
Code: NCT03401398
Phase 3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Boston MA, New Haven CT, Stony Brook NY, Lake Sucess NY,
Sponsor: Center for International Blood and Marrow Transplant Research